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Objective: The effect of population screening for abdominal aortic aneurysm (AAA) disease on morbidity and mortality
has been comprehensively studied and reported. However, the effect of early AAA detection on suitability for
endovascular aneurysm repair (EVAR) remains unknown. Considering the importance of such an effect on future health
economics, we sought to assess the possible effect of AAA ultrasound surveillance on suitability for EVAR.
Methods: This was a prospective cohort study. From January 2002 to August 2003, consecutive AAA patients selected for
open elective repair were placed into one of two groups according to mode of presentation. The first group included
patients referred from a local well-established AAA ultrasound screening and surveillance program (ultrasound surveil-
lance [AAA-S] group). The second group included patients referred from neighboring unscreened regions with
incidentally diagnosed AAA (incidental [AAA-I] group). All patients underwent preoperative computed tomographic
angiography. By using three-dimensional reconstruction software, computed tomographic images were assessed by two
blinded observers for suitability for EVAR by using the criteria for a modular endovascular device.
Results:Of 74 patients included in the study, 41 were in the AAA-S group, and 31 were in the AAA-I group. The median
aneurysm diameter was 72.3 mm (range, 50.7-83.7 mm) for AAA-I and 65 mm (range, 50.7-79.2 mm) for AAA-S
(P < .47). Suitability for EVAR was 41% in the AAA-S group and 45% in the AAA-I group (P < .47).
Conclusions:Early detection and surveillance of AAA does not seem to increase suitability for EVAR. Suitability for EVAR
seems to be determined early on in an aneurysm’s life. On the basis of current device technology, referral for intervention
from an AAA surveillance program may need to be initiated at a size well below 5.5 cm if an increase in EVAR suitability
is to be expected. (J Vasc Surg 2006;43:265-9.)In the last 3 years, the results from two major randomized
controlled trials regarding the management of abdominal
aortic aneurysm (AAA) disease were published. In 2002, we
demonstrated a clear reduction in aortic aneurysm–related
mortality in the screened population.1 In 2005, we also
demonstrated that endovascular aneurysm repair (EVAR)
does not confer a significant survival benefit over open
surgery for aneurysms 5.5 cm in diameter.2 Recently, the
US Preventive Task Force recommended screening for
AAA in men between the ages of 65 and 75 years.3 Because
the effect of early aneurysm detection regarding suitability
for EVAR remains unknown, and considering the impor-
tance of a possible effect on future health economics, we
sought to assess the effect of AAA ultrasound surveillance
on suitability for EVAR.
MATERIALS AND METHODS
From January 2002 to August 2003, consecutive AAA
patients selected for open elective repair in a single vascular
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is a mix between ultrasound-monitored aneurysms referred
through a local well-established aneurysm-screening pro-
gram and incidentally discovered aneurysms referred from
neighboring unscreened regions. Upon reaching the age of
65 years, local men automatically receive an invitation for
an aortic ultrasound scan from the AAA screening coordi-
nator. Of these, 85% present to one of several local screen-
ing clinics. Those with an aortic diameter of 30 mm or less
are classed as “normal” and are discharged. Those with a
30- to 45-mm diameter are offered a yearly surveillance
scan. Those who present with or reach a 45- to 54-mm
diameter are offered 3-monthly surveillance scans. Indica-
tions for surgery include aneurysm diameter greater than
55 mm, rapid expansion more than 10 mm/y (both mea-
surements identified by ultrasound surveillance), or symp-
tomatic aneurysms.
According to their mode of presentation, patients were
divided into two groups: AAA surveillance (AAA-S) and
AAA incidental (AAA-I). The AAA-S group included pa-
tients initially identified with small AAAs, which were mon-
itored via regular ultrasound scanning and were then re-
ferred for surgery upon fulfilling the above-mentioned
criteria. The AAA-I group included patients initially iden-
tified with a large AAA who required referral for surgery
from the outset.
When one or more criteria for surgery were met, pa-
tients underwent computed tomographic (CT) angiogra-
phy by using a multiplanar scanner with 2-mm slices.
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Images; Minnetonka, Minnesota Figs 1 and 2) was used to
assess suitability for deployment of a bimodular endovascu-
lar stent (Cook, Zenith, Australia). The CT images were
analyzed by two blinded analysts, and suitability for EVAR
was assessed according to the manufacturer’s criteria (Table
I). The emphasis of this study was on differential and not
overall EVAR suitability. Statistical analysis was performed
by using nonparametric tests, and statistical significance was
assumed at P  .05.
RESULTS
In total, 74 patients were considered for elective repair
of their aneurysms within the study period. Two patients
were excluded from the study after CT angiography. One
patient had a non–contrast-enhanced CT and could not
be adequately assessed, and one patient had a juxtarenal
aneurysm in a long neck after AAA repair in 1992. Of the
remaining 72 patients, 41 were in the AAA-S group, and
31 were in the AAA-I group. Patients in the AAA-S
group had a median of 9 surveillance ultrasound scans
(range, 1-32). None of the patients in this study was
offered EVAR.
Table II shows the demographic data for the patients
studied. The only significant difference between the two
groups was in history of hypercholesterolemia. Hypercho-
lesterolemia (cholesterol level of 4.8 mmol/L) is more
likely to be preidentified in the AAA-S patients because
these patients are routinely investigated for arterial disease
risk factors upon recruitment for surveillance. Table III
shows the various ultrasonographic and three-dimensional
reconstructed aortic measurements in the two groups. Pa-
Fig 1. Tomographic image of an aneurysm after three-dimensional
software enhancement. The calculated center of the aortic lumen and
perpendicular measurements are shown.tients in the AAA-I group had significantly larger aneu-rysms. In the AAA-S group, the median ultrasonographic
diameter at the time of referral to a clinician was less than
that detected by CT imaging. This is explained by the
difference in imaging techniques and the time lag between
referral and CT imaging. On average, it takes 3 months
between initiation of referral by the surveillance program
and completion of repair. This time is required for preop-
erative workup, seeking various specialist opinions, and
agreeing on a suitable admission date with the patient.
Table IV shows the criteria for EVAR suitability. The main
cause for EVAR unsuitability in the AAA-S group was a
juxtarenal aortic diameter of greater than 29 mm (50%).
The second cause was neck angulation greater than 69°
(45%), and the third was too much thrombus in the neck
(41%). For the AAA-I group, the most common causes for
EVAR unsuitability were unsuitable neck length, juxtarenal
aortic diameter greater than 29 mm, neck containing too
much thrombus, and neck angulation greater than 69°
(41% each) Overall, there was no significant difference in
EVAR suitability between the two groups.
DISCUSSION
The initial idea of conducting this study was based on
our intraoperative observation that screened aneurysms
tend to have longer necks. On this basis, we assumed that
ultrasound-monitored aneurysms were more likely to meet
the criteria for EVAR. This study was then designed to
examine this hypothesis. Although we did indeed demon-
strate that when compared with AAA-I patients, AAA-S
patients had more suitably long aneurysm necks for EVAR,
the difference between the two groups was statistically not
significant. Furthermore, we could not demonstrate either
Fig 2. Tomographic software enhancement showing the largest
dimension of the aneurysm sac calculated from the maximum area
perpendicular to the center of the aorta.a statistically significant difference in the overall suitability
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trend toward AAA-S.
Although the number of patients in this study was
relatively small, we believe that it is sufficient to give an
indication of the prevailing trend. A randomized controlled
trial would clearly provide more robust data; however, such
a trial will require no fewer than 790 patients. Recruiting
such a number in a relatively short period of time will
require a national aneurysm screening program. If such a
program existed, and according to current device technology
and criteria for intervention, then any increase in EVAR suit-
ability would be likely felt at a national rather than unit level.
In our cohort of patients, the predominant causes for
failing EVAR suitability were related to neck width and
angulation. In the AAA-S group, neck length did not
feature as a main cause for EVAR unsuitability, whereas in
the AAA-I group, it featured jointly with width and angu-
lation as the most common causes.
AAA disease has an estimated prevalence of 4.9% in
men between the ages of 65 and 74 years.1 Because most
AAAs remain asymptomatic until rupture, we have previ-
ously shown that early detection by screening in view of
targeted elective repair improves survival of this condition
significantly.1 There is now a considerable body of evidence
to support national screening, and indeed the US Preven-
Table I. Manufacturer’s suitability criteria for EVAR
Neck
No suprarenal dilatation 20 mm dia
Juxtarenal 18-28 mm in diameter; 15 mm
minimum length Length 10 m
20% dilatation 20 mm distal to
juxtarenal (funnel neck) Not too angu
Not overly calcified Not too tortu
Circumferential thrombus Not overly ca
70° angulation relative to long axis of
aneurysm and 45° relative to the axis
of the suprarenal aorta Significant oc
EVAR, Endovascular aneurysm repair.
Table II. Patient demographics
Variable
AAA-S
(n  41)
AAA-I
(n  31) P value
Male/female 41/0 25/6
Smoker 12 10 .47*
Ex-smoker 20 13 .5*
Hypertension 26 19 .56*
Family history 5 1 .18*
Diagnosed
hypercholesterolemia 19 5 .004*
Ischemic heart disease 19 10 .16*
Age, y, mean (range) 73 (65-86) 77 (55-86) .2†
AAA-S, Surveillance group; AAA-I, incidental finding group.
*Fisher exact test.
†Analysis of variance.tive Services Task Force has issued recommendations to thiseffect.3 One of the advantages of AAA surveillance is to be
able to monitor aneurysm growth and to accurately stan-
dardize the size for intervention. In our screened group,
the median number of surveillance ultrasound scans was
nine per patient. This number of scans usually spans a
minimum of 2 years, thus allowing us sufficient time to
optimize our patients medically. This explains the signifi-
cantly higher incidence of already-identified risk factors in
the AAA-S group.
EVAR was first introduced by Parodi et al4 in 1991.
Since then, EVAR devices have been in a steady state of
evolution. Currently, advocates for this technique claim
that early technical difficulties have been overcome and that
EVAR’s future is assured. However, others believe that
there is already sufficient evidence to warrant caution in the
use of EVAR.5-7 Reports on EVAR to date have been
influenced considerably by selection and operator bias as-
sociated with pioneering a new technique. In addition, the
continuous updating of techniques and materials means
Iliacs Other
No visceral arterial disease
nimum; 20 mm preferable Femoral access 8 mm
n or thrombus lining
Table III. Aneurysm measurements (mm)
Variable
AAA-S
(n  41)
AAA-I
(n  31)
P
value*
USS AAA diameter
(at time of
referral to
clinician) 58 (40-68)
CT AAA maximum
diameter 64 (55.7-82.1) 72 (66.2-90.7)
3D AAA maximum
diameter 65.2 (54.7-80) 72.3 (50.7-83.7) 000
CT minimum
suprarenal 27.8 (24.5-29.4) 26.7 (19.9-35.6)
3D minimum
suprarenal 28.2 (24.5-34.8) 28.6 (24.4-38.7)
CT maximum
juxtarenal 29.7 (23.6-41.4) 27.5 (21.1-45.5)
3D maximum
juxtarenal 27.6 (22.3-42) 24.7 (20.8-48.4)
AAA-S, Surveillance group;AAA-I, incidental finding group;AAA, abdominal
aortic aneurysm; USS, ultra-sound scan; CT, computed tomography; 3D,
three-dimensional.
*Mann-Whitney U test.meter
m mi
lated
ous
lcified
clusiothat it may be some time before the longer-term outcomes
incide
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and long-term results from various randomized EVAR
trials indicate that the short-term gains of this new technol-
ogy are offset by the considerable long-term complications
and costs.8,9 Although in our unit (St Richard’s hospital)
we believe in the concept of endovascular intervention, we
do not offer EVAR to our patients as of yet. With a
mortality rate of 2% for our open elective screened AAA
repairs, we do not believe that the current EVAR technol-
ogy has much to offer to our patients.
Although for this study we used the EVAR suitability
criteria for one device only, this device is favored by many
because of its versatility, which is attributed to its ability to
cope with wide-diameter implant zones.10,11 This feature is
of particular importance because the most common cause
for unsuitability in our group of patients is neck dilatation.
This device has long-term complication rates comparable
to those of other devices.12 We did deem analyzing our
data according to other device criteria unnecessary. This
decision was based on the fact that the main cause for
EVAR unsuitability in our patients was neck dilatation. The
device criteria we chose compare well with some of the
other main devices,10 which were unlikely to alter our
findings if their criteria were used.
The most comprehensive cohort of EVAR cases offered
for peer review so far has been delivered by the EUROSTAR
collaborative. The collaborative reported a reintervention rate
of 18% at a mean of 14 months, with a 62% freedom from
reintervention at 4 years.13 This emphasizes the need for
intensive follow-up with those undergoing EVAR and must
be considered in addition to the morbidity and mortality of
the procedure. The collaborative has also concluded that
smaller aneurysms are much more suited for EVAR, with
fewer requirements for long-term postrepair follow-up.14 On
this basis, it is possible that the threshold for EVAR interven-
tion may be lowered in the future.
Although debating the case for offering EVAR to pa-
tients with aneurysms of less than 5.5 cm is outside the
Table IV. Cause for EVAR unsuitability
Variable AAA
Suitability for EVAR 17
Suprarenal dilatation 0
Neck length unsuitable 8
Juxtarenal aortic diameter 29 mm 12
20% dilatation 20 mm distal to juxtarenal 6
Neck overly calcified 0
Neck containing too much thrombus 10
Neck 69° angulation 11
Iliacs 19 mm 6
Iliac too long for device 1
Iliac too angulated 0
Iliac too tortuous 3
Iliac too calcified 0
Iliac containing too much thrombus 1
Internal iliac occlusion 0
EVAR, Endovascular aneurysm repair; AAA-S, surveillance group; AAA-I,scope of this study, our data suggest that on the basis ofcurrent device technology, referral for intervention from an
AAA surveillance program may need to be initiated at a size
well below 5.5 cm if an increase in EVAR suitability is to be
expected.
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The authors compared the suitability for endovascular repair
(EVAR) in patients with incidentally diagnosed and screen-
detected aneurysms. In view of the potential effects on the future
health economics of aneurysm screening and EVAR, this is a topic
of considerable interest. The study was initiated after the authors’
observation that screen-detected aneurysms tended to have longer
infrarenal necks. However, early abdominal aortic aneurysm
(AAA) detection did not lead to an increase in suitability for EVAR
in this study.
Before the outcome of this study is accepted, several issues
must be addressed. First, the study lacks a proper power analysis,
and with recruitment arms of 41 and 31 patients, a type II error is
imminent. One may further question the efficacy of the ultrasound
screening program to which the study population was exposed,
because the median aneurysm diameter upon referral was 65 mm
(range, 51-79 mm), after a mean of nine surveillance scans per
patient, typically spanning a minimum of 2 years. As a result, the
screen-detected aneurysms were relatively large at the time of
referral, whereas EVAR suitability is expected to be higher in
smaller AAAs. The study was conducted in a vascular center where
EVAR is not offered as a treatment option, and all patients under-eijn, MD, PhD, Nijmegen, The Netherlands
experience will tend to use rather rigid criteria for this treatment
option as compared with EVAR centers. Common indications for
surgery were applied in this study: aneurysm diameter larger than
55 mm, rapid expansion of more than 10 mm/y, or a tender
aneurysm. This is in accordance with most EVAR studies. The
determination of suitability for EVAR, however, depended on
the—rather poorly defined—manufacturer’s criteria for a single
device, whereas in most endovascular programs, EVAR eligibility is
determined on the basis of the availability of multiple devices. In
addition, suitability for EVAR is never an objective qualification,
irrespective of manufacturer’s guidelines, which are commonly
rather conservative (for understandable reasons). Many clinicians,
for instance, consider neck thrombus not to be a contraindication
to EVAR, although this was the second most common exclusion
criterion in this study. This may be an explanation for the low rates
of suitability for EVAR of 41% and 45% in the screen-detected and
incidentally diagnosed AAAs, respectively, whereas in many centers
60% of AAA patients receive an endograft. It is quite possible that
with more liberal criteria for EVAR, screen-detected aneurysms
would have shown a higher suitability rate than the incidentally
diagnosed aneurysms. Caution is therefore appropriate in the
interpretation and generalization of the outcome of this study.
